JULIE BRAUN: Open Payments
NPI 1396745873 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,027 in 38 payments from 18 companies in 2025. Trend: 2023 $786 · 2024 $2,331 · 2025 $1,027
Food & beverage: $1,027
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 6 | $159 |
| Otsuka America Pharmaceutical, Inc. | 6 | $141 |
| Edwards Lifesciences Corporation | 1 | $131 |
| PFIZER INC. | 3 | $127 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Merck Sharp & Dohme LLC | 3 | $63 |
| Radius Health, Inc. | 3 | $62 |
| Amgen Inc. | 2 | $49 |
| Lundbeck LLC | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
Products named: REXULTI, VOQUEZNA, PREVNAR 20, CAPLYTA, GARDASIL 9, Tymlos, OTEZLA, FANAPT.
Industry payments across NV — which companies pay providers there.
